One of the most translationally relevant findings of the current study is the identification of an AHR ligand that can prevent NEC, either when offered orally during pregnancy (Fig. 6p–t), or when administered directly to the neonatal pups (Fig. 6h–k). The gene discussed is AHR; the disease is necrotizing enterocolitis.